Inovio Pharmaceuticals, Inc. - Common Stock (INO)
$1.98
0.04 (1.98%)
INO Stock Quote Delayed 30 Minutes
INO Stock Earnings: Inovio Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
INO stock results show that Inovio Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
416.51M
PE Ratio
-0.44
EPS
-4.47
Volume (Avg. Vol.)
618,102
Day's Range
$1.90 - $2.05
52-Week Range
$1.74 - $14.75
Dividend & Yield
N/A (N/A)
INO Stock Predictions, Articles, and Inovio Pharmaceuticals, Inc. - Common Stock News
Why Is Inovio Pharmaceuticals (INO) Stock Down Today?
Inovio Pharmaceuticals stock is falling on Wednesday as the company prepares for a 1-for-12 reverse stock split for INO.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers on Tuesday with a breakdown of all the latest news affecting shares this morning.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of the week with a breakdown of the biggest pre-market stock movers worth watching on Friday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to tackle the biggest pre-market stock movers for this morning as we get ready for trading hours to start on Thursday!
INO Stock Plunges 25% as Inovio Pharmaceuticals Swaps Vaccine Focus
Inovio Pharmaceuticals has halted its Covid-19 progress to focus on a booster. Here's why this news is unlikely to boost INO stock.
INO Stock: The Covid-19 Vaccine News Helping Inovio Power Higher
Inovio Pharmaceuticals (INO) stock is pushing higher on Tuesday after providing investors with an update on its Covid-19 vaccine.
Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships
Some say INO stock could be the target of a short squeeze, but Inovio's Covid-19 vaccine program should be a sufficient reason to invest.
INO Stock: 2 Big Reasons Inovio Pharmaceuticals Is Shooting Higher Today
Today, INO stock is soaring amid a recently announced expanded partnership for its Covid-19 vaccine and potential short squeeze implications.
I Would Hope Inovio Isn’t Attracting ANY Serious Money
A recent article wondered if the smart money preferred Ocugen or Inovio. I would hope neither INO stock or OCGN is getting any serious money.
4 Top Stock Trades for Monday: SNAP, INTC, HON, INO
Snap, Intel, Honeywell and Inovio were our top stock trades for Monday. That said, let's look at how the charts are setting up now.
Sell Inovio While You Still Can
INO stock is poised to fall further as the chances of a vaccine approval fall and its competitors widen their lead
Don’t Sleep on Inovio Pharmaceuticals as a Serious Vaccine Contender
When will INO stock finally turn a corner? That's a question on some investor's minds, and recent data suggests a turnaround might be afoot.
Reality Hits Home for Shares of Inovio Pharmaceuticals
Shares of INO stock is being held back by a delayed clinical trial for Inovio’s vaccine candidate to combat the coronavirus.
Just Say No to Inovio Pharmaceuticals Stock
While INO stock has boasted a banner year, Inovio appears no closer to a Covid-19 vaccine than any of the other 150 contenders.
